Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
MacroGenics
ImmunityBio, Inc.
Mayo Clinic
Merck Sharp & Dohme LLC
Telix Pharmaceuticals (Innovations) Pty Limited
Oslo University Hospital
Seagen Inc.
UNICANCER
OncoNano Medicine, Inc.
Seagen Inc.
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
BIND Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoag Memorial Hospital Presbyterian